# Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

> **NCT02252809** · EARLY_PHASE1 · COMPLETED · sponsor: **Brugmann University Hospital** · enrollment: 51 (actual)

## Conditions studied

- Innate Immunity

## Interventions

- **DRUG:** adalimumab
- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT02252809
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252809, "Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02252809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*